Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1050 | Male Reproduction | ICEECE2012

Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats

Morelli A. , Sarchielli E. , Comeglio P. , Filippi S. , Mancina R. , Gacci M. , Vignozzi L. , Carini M. , Vannelli G. , Maggi M.

Introduction: In humans, prostate PDE5 expression was prominently localized in the endothelial and smooth muscle cells of the vascular bed, suggesting a possible action of PDE5 inhibitors on prostate blood flow.Aim: To investigate PDE5 expression in human and rat lower urinary tract (LUT) tissues and determine the effects of PDE5 inhibition with tadalafil on prostatic blood perfusion.Main outcome measures: Human vesicular-deferenti...

ea0029p1207 | Obesity | ICEECE2012

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

Vignozzi L. , Morelli A. , Sarchielli E. , Comeglio P. , Filippi S. , Cellai I. , Maneschi E. , Serni S. , Gacci M. , Carini M. , Piccinni M. , Saad F. , Adorini L. , Vannelli G. , Maggi M.

Metabolic syndrome (MetS) and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) are often associated. One of their common denominators is hypogonadism. However, testosterone supplementation is limited by concerns for potential prostatic side effects. The objective was to determine whether MetS-associated prostate alterations are prevented by testosterone supplementation. We used a previously described animal model of MetS, obtained by feeding male rabbits ...